Log in to save to my catalogue

Substance P receptor antagonists in psychiatry: Rationale for development and therapeutic potential

Substance P receptor antagonists in psychiatry: Rationale for development and therapeutic potential

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67713097

Substance P receptor antagonists in psychiatry: Rationale for development and therapeutic potential

About this item

Full title

Substance P receptor antagonists in psychiatry: Rationale for development and therapeutic potential

Author / Creator

Publisher

Hong Kong: Adis International

Journal title

CNS drugs, 2005-01, Vol.19 (4), p.275-293

Language

English

Formats

Publication information

Publisher

Hong Kong: Adis International

More information

Scope and Contents

Contents

Increasing evidence suggests that substance P (SP) and its receptor (neurokinin [NK]-1 receptor [NK1R]) might play an important role in the modulation of stress-related, affective and/or anxious behaviour. First, SP and NK1R are expressed in brain regions that are involved in stress, fear and affective response (e.g. amygdala, hippocampus, hypothal...

Alternative Titles

Full title

Substance P receptor antagonists in psychiatry: Rationale for development and therapeutic potential

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_67713097

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67713097

Other Identifiers

ISSN

1172-7047

E-ISSN

1179-1934

DOI

10.2165/00023210-200519040-00001

How to access this item